4/A//SEC Filing
ANADYS PHARMACEUTICALS INC 4/A
Accession 0001104659-05-027201
CIK 0001128495operating
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 9:28 PM ET
Size
40.0 KB
Accession
0001104659-05-027201
Insider Transaction Report
Form 4/AAmended
HBM BIOVENTURES AG
10% Owner
Transactions
- Sale
Common Stock
2005-06-02$8.59/sh−1,610$13,830→ 2,615,195 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.70/sh−300$2,610→ 2,603,145 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.45/sh−1,800$15,210→ 2,645,175 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.60/sh−5,310$45,666→ 2,609,885 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.76/sh−290$2,540→ 2,600,555 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.46/sh−2,909$24,610→ 2,642,266 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.62/sh−1,350$11,637→ 2,605,445 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.50/sh−1,391$11,824→ 2,637,825 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.47/sh−1,000$8,470→ 2,641,266 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.49/sh−2,000$16,980→ 2,639,216 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.52/sh−6,470$55,124→ 2,621,605 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.80/sh−2,400$21,120→ 2,597,055 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.79/sh−1,100$9,669→ 2,599,455 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.51/sh−9,750$82,973→ 2,628,075 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.55/sh−2,500$21,375→ 2,619,105 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.87/sh−428$3,796→ 2,596,627 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.68/sh−100$868→ 2,603,445 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.64/sh−1,900$16,416→ 2,603,545 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.48/sh−50$424→ 2,641,216 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.58/sh−2,300$19,734→ 2,616,805 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.61/sh−3,090$26,605→ 2,606,795 total(indirect: By HBM BioVentures (Cayman) Ltd.)
Footnotes (1)
- [F1]HBM BioVentures AG (the "Reporting Entity") is the sole shareholder of HBM BioVentures (Cayman) Ltd. ("HBM"), the entity that owns the reported securities.
Documents
Issuer
ANADYS PHARMACEUTICALS INC
CIK 0001128495
Entity typeoperating
Related Parties
1- filerCIK 0001128495
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 9:28 PM ET
- Size
- 40.0 KB